Join OHBM for a virtual symposium and live Q&A generously hosted and sponsored by
GE HealthCare

Mark your calendars for December 11, 2023, as we delve into the fascinating realm of advanced tractography for personalized neuropsychiatric care with leading experts in the field! 


Date: Monday, December 11, 2023
Time: 8:00am CST, USA
Price: This is a free event!



Personalized Neuromodulation Planning Using White Matter Tracts

Presented by Helen S. Mayberg, MD, and Ki Sueng Choi, PhD

The DBS research field is evolving from the focal effects of stimulation on the target anatomical structure to its impact on distributed brain networks. This development is paralleled by the growth of the “connectome” in neuroimaging. This presentation will discuss the tractography-based connectome approach applied to subcallosal cingulate DBS for treatment-resistant depression and ALIC DBS for OCD, as well as the prospective testing of the connectome approach in a new cohort of depression subjects.

Push Button Advanced Tractography for Quantitative Assessment of White Matter Tracts

Presented by Maxime Descoteaux, PhD

Human brain white matter is composed of approximately 100,000 miles of axons. Diffusion MRI is used to assess white matter non-invasively and quantitatively. This presentation will discuss a novel push button solution for advanced tractography that goes beyond classical diffusion tensor imaging (DTI). Additionally, the validation, security, and quality management necessary for a tool such as ANDI to obtain FDA-clearance will also be discussed. 

Live Q&A

Join Helen S. Mayberg, MD, Ki Sueng Choi, PhD, and Maxime Descoteaux, PhD for a live Q&A immediately following the presentations.

To secure your spot, please register for this free event using the registration link.

We look forward to your participation and lively engagement during the webinar. Don't miss the chance to be part of this enriching symposium!

Please note that this webinar is not affiliated with an ACCME Accredited program. In the event that speakers or their respective institutions derive financial benefits from their involvement in this webinar, it is important to clarify that such circumstances do not constitute a conflict of interest. The organizers aim to uphold transparency and ensure that any potential financial interests do not compromise the integrity and impartiality of the webinar content. The speakers for this GE HealthCare sponsored webinar have not been compensated for their participation or preparation by GEHC or OHBM.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 51,000 employees working to create a world where healthcare has no limits.